
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 96.660 | 96.660 | 0.000 |
Bonds | 1.830 | 1.830 | 0.000 |
Other | 1.520 | 1.520 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 14.708 | 14.702 |
Price to Book | 2.175 | 2.046 |
Price to Sales | 1.506 | 1.469 |
Price to Cash Flow | 8.189 | 9.150 |
Dividend Yield | 3.519 | 3.372 |
5 Years Earnings Growth | 8.348 | 9.042 |
Name | Net % | Category Average |
---|---|---|
Financial Services | 21.510 | 20.180 |
Industrials | 19.580 | 16.947 |
Healthcare | 14.310 | 13.743 |
Consumer Defensive | 9.810 | 10.983 |
Consumer Cyclical | 8.540 | 9.403 |
Technology | 8.080 | 9.119 |
Communication Services | 5.230 | 5.562 |
Utilities | 4.640 | 4.733 |
Energy | 4.520 | 4.289 |
Basic Materials | 3.780 | 6.282 |
Number of long holdings: 65
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AstraZeneca | GB0009895292 | 3.93 | 10,160.0 | -0.45% | |
SAP | DE0007164600 | 3.55 | 256.775 | -0.55% | |
Enel | IT0003128367 | 3.50 | 8.190 | +0.37% | |
Siemens AG | DE0007236101 | 3.17 | 220.05 | -0.56% | |
ASML Holding | NL0010273215 | 3.09 | 670.20 | -1.02% | |
Danone | FR0000120644 | 3.01 | 68.98 | -0.06% | |
Shell | GB00BP6MXD84 | 2.70 | 30.48 | -0.41% | |
Swiss Re | CH0126881561 | 2.53 | 137.90 | +0.00% | |
Sanofi | FR0000120578 | 2.46 | 82.07 | -0.49% | |
AXA | FR0000120628 | 2.19 | 41.27 | -0.31% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Exane Funds 2 Exane Equity Select E | 712.03M | 10.69 | 10.60 | 6.33 | ||
Exane Funds 2 Exane Equity Select f | 712.03M | 10.87 | 11.04 | 6.61 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review